
Jonathan G. Sterrett
Examiner (ID: 9327)
| Most Active Art Unit | 3623 |
| Art Unit(s) | 3623 |
| Total Applications | 825 |
| Issued Applications | 274 |
| Pending Applications | 34 |
| Abandoned Applications | 517 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5368410
[patent_doc_number] => 20090305969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/085220
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7356
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085220 | Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5343238
[patent_doc_number] => 20090181888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/085221
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8237
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181888.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085221 | Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5253888
[patent_doc_number] => 20070135344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Novel growth factor and a genetic sequence encoding same'
[patent_app_type] => utility
[patent_app_number] => 11/602055
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 9373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602055
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602055 | Novel growth factor and a genetic sequence encoding same | Nov 19, 2006 | Abandoned |
Array
(
[id] => 4823026
[patent_doc_number] => 20080227711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Cxc-Chemokine Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/067221
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067221 | CXC-chemokine antagonists isolated from Rhipicephalus sanguineus | Oct 29, 2006 | Issued |
Array
(
[id] => 4970733
[patent_doc_number] => 20070110735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Methods for regulating angiogenesis and vascular integrity using trk receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/589659
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14199
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11589659
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/589659 | Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands | Oct 29, 2006 | Issued |
Array
(
[id] => 5224697
[patent_doc_number] => 20070253963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Epithelial cell specific growth factor keratinocyte growth factor (KGF)'
[patent_app_type] => utility
[patent_app_number] => 11/585862
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15351
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11585862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/585862 | Epithelial cell specific growth factor keratinocyte growth factor (KGF) | Oct 24, 2006 | Abandoned |
Array
(
[id] => 5410657
[patent_doc_number] => 20090124556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Peptides Exhibiting Efficacies of Improvement in Skin Conditions or Treatment of Periodental Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/083970
[patent_app_country] => US
[patent_app_date] => 2006-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9295
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083970
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083970 | Method for improving skin conditions | Oct 23, 2006 | Issued |
Array
(
[id] => 13651
[patent_doc_number] => 07807628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Therapeutic agent for dentin-pulp complex regeneration'
[patent_app_type] => utility
[patent_app_number] => 12/083734
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 6674
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083734
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083734 | Therapeutic agent for dentin-pulp complex regeneration | Oct 18, 2006 | Issued |
Array
(
[id] => 4550374
[patent_doc_number] => 07820396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Method for determining atopic dermatitis using protein marker'
[patent_app_type] => utility
[patent_app_number] => 12/090644
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 12698
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820396.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090644
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090644 | Method for determining atopic dermatitis using protein marker | Oct 18, 2006 | Issued |
Array
(
[id] => 5052097
[patent_doc_number] => 20070032642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Novel genes and their use in the modulation of obesity, diabetes and energy imbalance'
[patent_app_type] => utility
[patent_app_number] => 11/544140
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18381
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544140 | Novel genes and their use in the modulation of obesity, diabetes and energy imbalance | Oct 5, 2006 | Abandoned |
Array
(
[id] => 5527728
[patent_doc_number] => 20090197805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Insulin receptor antagonists and related compositions, uses and methods'
[patent_app_type] => utility
[patent_app_number] => 12/089222
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17687
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089222
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089222 | Insulin receptor antagonists and related compositions, uses and methods | Oct 2, 2006 | Abandoned |
Array
(
[id] => 5126388
[patent_doc_number] => 20070238659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTORS HAVING ANTAGONISTIC PROPERTIES, NUCLEIC ACIDS ENCODING THE SAME AND HOST CELLS COMPRISING THOSE NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 11/536547
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16830
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11536547
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/536547 | VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTORS HAVING ANTAGONISTIC PROPERTIES, NUCLEIC ACIDS ENCODING THE SAME AND HOST CELLS COMPRISING THOSE NUCLEIC ACIDS | Sep 27, 2006 | Abandoned |
Array
(
[id] => 5242847
[patent_doc_number] => 20070021342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Wound Healing'
[patent_app_type] => utility
[patent_app_number] => 11/535032
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19667
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021342.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535032 | Wound Healing | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5005492
[patent_doc_number] => 20070203063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS INCLUDING VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR HAVING ALTERERD PHARMACOLOGICAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 11/533301
[patent_app_country] => US
[patent_app_date] => 2006-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12168
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11533301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/533301 | PHARMACEUTICAL COMPOSITIONS INCLUDING VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR HAVING ALTERERD PHARMACOLOGICAL PROPERTIES | Sep 18, 2006 | Abandoned |
Array
(
[id] => 6455082
[patent_doc_number] => 20100145441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 12/067593
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18840
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20100145441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067593 | THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5453196
[patent_doc_number] => 20090069233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing'
[patent_app_type] => utility
[patent_app_number] => 12/066786
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2409
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066786
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066786 | Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing | Sep 10, 2006 | Abandoned |
Array
(
[id] => 5258758
[patent_doc_number] => 20070212390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Protease-resistant forms of VEGF-D, method of making and method of use'
[patent_app_type] => utility
[patent_app_number] => 11/517290
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8761
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11517290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/517290 | Protease-resistant forms of VEGF-D, method of making and method of use | Sep 7, 2006 | Abandoned |
Array
(
[id] => 5135994
[patent_doc_number] => 20070077623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/518609
[patent_app_country] => US
[patent_app_date] => 2006-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 139
[patent_figures_cnt] => 139
[patent_no_of_words] => 117361
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518609 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 6, 2006 | Abandoned |
Array
(
[id] => 6593554
[patent_doc_number] => 20100048465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Peptide mimics of melanocyte stimulating hormone'
[patent_app_type] => utility
[patent_app_number] => 11/991121
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19246
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991121 | Peptide mimics of melanocyte stimulating hormone | Aug 31, 2006 | Issued |
Array
(
[id] => 6055100
[patent_doc_number] => 20110111460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Method for Making Mature Insulin Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/063692
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13172
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20110111460.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063692 | Method for making mature insulin polypeptides | Aug 14, 2006 | Issued |